[1]苏莉,黄诚刚,牛文强,等.25例血清PTH升高的甲状旁腺相关疾病患者的诊断[J].国际放射医学核医学杂志,2010,34(2):84-87.[doi:10.3760/cma.j.issn.1673-4114.2010.02.005]
　SU Li,HUANG Cheng-gang,NIU Wen-qiang,et al.Nuclear medicine diagnostic experience for 25 patients with parathyroid disease accompanied elevated serum PTH level[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):84-87.[doi:10.3760/cma.j.issn.1673-4114.2010.02.005]
点击复制

25例血清PTH升高的甲状旁腺相关疾病患者的诊断(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
34
期数:
2010年第2期
页码:
84-87
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Nuclear medicine diagnostic experience for 25 patients with parathyroid disease accompanied elevated serum PTH level
作者:
苏莉;  黄诚刚;  牛文强;  邬礼文
湖北孝感市中心医院核医学科, 432100
Author(s):
SU Li;  HUANG Cheng-gang;  NIU Wen-qiang;  WU Li-weng
Department of Nuclear Medicine, Xiaogan Central Hospital, Xiaogan 432100, China
关键词:
甲状腺功能亢进; 原发性; 甲状旁腺功能亢进症; 继发性; 甲状旁腺素; 体层摄影术; 发射型计算机; 单光子; 99m锝甲氧基异丁基异腈; 99m锝美罗酸盐
Keywords:
Hyperparathyroidism; primary; Hyperparathyroidism; secondary; Parathyroid hormone; Tomography; emission-computed; single-photon; Technetium 99Tcm sestamibi; Technetium 99Tcm medronate
DOI:
10.3760/cma.j.issn.1673-4114.2010.02.005
摘要:
目的 探讨血清甲状旁腺激素(PTH)升高的甲状旁腺相关疾病的核医学诊断方法和体会。方法 对25例甲状旁腺相关疾病患者进行99Tcm-MIBI SPECT双时相法甲状旁腺显像及99Tcm-亚甲基二膦酸盐(99Tcm-MDP)全身骨静态显像法显像,同时测定血清PTH和血清钙、磷及碱性磷酸酶含量。结果 ①原发性甲状旁腺功能亢进(PHPT)和继发性甲状旁腺功能亢进(SHPT)者血清PTH水平呈不同程度升高,其中PHPT较明显。②PHPT和SHPT患者手术前后PTH水平的变化明显,t分别为6.24和6.85,P均<0.01;③PHPT患者全身骨显像常呈典型的代谢性骨病骨显像特点,甲状旁腺99Tcm-MIBI双时相显影阳性率为90%以上;④SHPT患者全身骨显像表现多样,常因血本底偏高,骨/组织放射性计数值降低,使骨显像的清晰度受到影响,但通常以骨摄取显像剂增多为主。99Tcm-MIBI双时相甲状旁腺显像多有不同程度的甲状旁腺增生,达56%以上。结论 甲状旁腺、全身骨SPECT检查结合血清PTH水平测定的方法对甲状旁腺相关疾病的诊断及指导治疗具有很高的临床应用价值。
Abstract:
Objective To explore nuclear medicine diagnostic method for parathyroid disease accompanied elevated serum parathyroid hormone(PTH) level. Methods The images of 25 patients with parathyroid disease were obtained by SPECT 99Tcm-MIBI double-phase parathyroid imaging and 99Tcm-methylene diphosphonate(99Tcm-MDP) whole-body static bone imaging. All subject were measured serum PTH, calcium, phosphorus and alkaline phosphatase. Results ①Serum PTH level increased to varying degrees in patients with primary hyperparathyroidism(PHPT), secondary hyperparathyroidism(SHPT).② PHPT and SHPT showed significant change before and after surgery(t=6.24 and t=6.85, P<0.01).③The whole-body static bone images of PHPT patients were characterized by metabolic bone disease images. The positive rates of 99Tcm-MIBI were above 90%. ④ Whole-body bone imaging results of SHPT patients showed complex and diverse caused by high background, increased uptakes mainly.99Tcm-MIBI dual-phase parathyroid imaging showed hyperparathyroidism in varying degree, up to 56% or more. Conclusion Determination of serum PTH combined SPECT for parathyroid and whole-body bone imaging showed high clinical value in diagnosis and treatment of parathyroid disease.

参考文献/References:

[1] 韩恩昆,刘自宽,高硕,等.影像学检查在原发性甲状旁腺功能亢进症术前定位中的作用.中华普通外科杂志,2004,19(4):219-221.
[2] Taillefer R,Boucher Y,Poctvin C,et al,Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sesta-mibi(double-phase study),J Nucl Med,1992,33(10):1801-1807.
[3] 刘新杰,周冬仙.甲状旁腺激素测定在继发性甲状旁腺功能亢进手术中应用的进展,中国普通外科杂志,2008,17(11):1124-1126.

相似文献/References:

[1]彭诗瑶,李盼丽,张艾米,等.99Tcm-MIBI SPECT/CT融合断层显像在甲状旁腺功能亢进症中的应用价值[J].国际放射医学核医学杂志,2018,(3):195.[doi:10.3760/cma.j.issn.1673-4114.2018.03.001]
　Peng Shiyao,Li Panli,Zhang Aimi,et al.Importance of 99Tcm-MIBI SPECT/CT fusion imaging in primary and secondary hyperparathyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):195.[doi:10.3760/cma.j.issn.1673-4114.2018.03.001]
[2]王任飞,田小丽,谭建,等.腰椎能谱CT评估Graves甲状腺功能亢进症患者131I治疗前后骨量变化的价值[J].国际放射医学核医学杂志,2018,(6):495.[doi:10.3760/cma.j.issn.1673-4114.2018.06.004]
　Wang Renfei,Tian Xiaoli,Tan Jian,et al.Changes of bone mass in patients with Graves’ hyperthyroidism before and after 131I therapy based on CT spectral imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):495.[doi:10.3760/cma.j.issn.1673-4114.2018.06.004]

备注/Memo

备注/Memo:
收稿日期:2009-11-25。
通讯作者:黄诚刚(E-mail:xghch@163.com)
更新日期/Last Update: 1900-01-01